Feasibility and Safety of Pressurized Intraperitoneal Aerosol Chemotherapy for Peritoneal Carcinomatosis: A Retrospective Cohort Study

Table 2

Surgical details of pressurized intraperitoneal aerosol chemotherapy (PIPAC).

	Overall ()	GYN ()	Digestive ()	value
Surgical feasibility
Number of trocars	2 (2-3)	2 (2-3)	2 (2-3)	0.668
Operation time	94 (89–108)	91 (87–97)	100 (92–117)	0.002
Intra-OP findings
PCI	10 (5–17)	9 (4–14)	15 (7–19)	0.002
Ascites (mL)	50 (0–4000)	0 (0–300)	50 (0–4000)	0.982
Adhesiolysis	15 (16%)	9 (18%)	6 (15%)	0.735
Median E-PASS	−0.20 (−0.32–−0.11)	−0.20 (−0.31–−0.10)	−0.20 (−0.31–−0.09)	0.733

Median (range) for number of trocars and ascites and median (IQR) for operation time, PCI, and E-PASS. Statistical significance () is highlighted in italics.
PCI: peritoneal cancer index; E-PASS: Modified Estimation of Physiologic Ability and Surgical Stress.